TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
CAI

Caris Life Sciences, Inc.

Healthcare · Biotechnology · —

29.70$ +8.0% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios CAI
Line item Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 148.8 47.9
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 13.8 13.9 9.6 5.6 5.1
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 16.3 18.8 13.6 8.5 8.5
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 13.2 13.3 9.1 5.1 4.8
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 651.0 41.5 27.5
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 117.0 41.0 34.4
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – -1.9% -0.2% 0.9% 2.4% 2.9%
Margins
66.4% 66.1% 65.7% 65.3% 64.6% 62.5% 50.5% 48.7% 46.4% 41.5% 46.7% 44.3% 43.4% 46.1% 48.6% 49.9% 50.3% 50.1% 49.4% 49.3% 49.0% 48.8% 48.3% 48.1% 50.8% 54.0% 57.8% 58.3% 69.0% 66.1% – – – 43.4% 46.3% 53.5% 59.9% 66.4% 68.7% 69.7%
44.1% 43.4% 42.6% 42.1% 41.5% 39.2% 27.3% 24.8% 22.0% 16.6% 22.4% 21.2% 21.8% 27.0% 30.3% 33.0% 34.7% 35.0% 34.4% 33.8% 33.2% 32.5% 31.2% 31.2% 33.2% 36.2% 42.6% 51.1% 55.3% 60.9% – – – -29.9% -19.6% -25.8% -6.8% 10.0% 15.9% 15.5%
26.9% 26.7% 26.5% 25.7% 25.0% 22.9% 10.7% 7.9% 4.2% -2.5% 2.0% 1.3% 4.1% 10.9% 20.7% 23.2% 23.8% 23.3% 18.2% 17.9% 15.4% 9.7% 7.3% 2.7% 0.3% 5.9% 8.6% 21.6% 33.4% 41.9% – – – -68.4% -60.4% -52.3% -28.8% -8.4% 3.7% 10.6%
-48.1% -49.7% -73.7% -75.1% -101.8% -99.3% -96.9% -78.9% -53.3% -43.9% -41.4% -41.7% -36.2% -65.8% -99.6% -109.9% -123.9% -137.4% -146.5% -144.3% -109.7% -71.2% -15.3% 12.9% 20.5% 42.7% 17.8% -23.5% -48.3% -197.1% – – – -61.5% -46.9% -26.3% -2.2% 8.2% 13.6% 14.8%
Returns
13.8% 14.0% 13.6% 13.0% 12.5% 11.7% 5.8% 4.4% 2.4% -1.5% 1.3% 0.9% 2.7% 7.2% 12.8% 13.5% 14.6% 13.7% 11.2% 11.4% 10.0% 6.2% 4.5% 1.6% 0.2% 3.1% 3.9% 8.9% 13.7% 17.4% – – – – – -61.6% -39.1% -11.8% 5.7% 17.8%
3.4% 3.3% 3.4% 3.2% 3.0% 2.8% 1.4% 1.0% 0.6% -0.3% 0.3% 0.2% 0.6% 1.5% 3.0% 3.3% 3.4% 3.2% 2.6% 2.7% 2.3% 1.4% 1.1% 0.4% 0.0% 0.7% 1.1% 2.4% 3.5% 4.3% – – – -82.0% -93.8% -29.2% -19.0% -6.0% 2.9% 8.6%
Balance Sheet & Debt
184 134 150 168 170 70 120 61 58 62 49 53 87 98 97 125 119 156 266 271 256 261 172 108 203 460 130 136 78 115 – – – 2.2 352 -338 -370 -419 -434 -291
1.1 0.7 0.8 0.9 0.9 0.4 0.7 0.3 0.3 0.4 0.3 0.3 0.5 0.5 0.4 0.5 0.5 0.6 0.9 0.9 0.9 0.9 0.7 0.5 0.9 2.0 0.5 0.5 0.3 0.4 – – – – – – – -36.8 -3.9 -1.7
24.2% 23.8% 24.6% 24.4% 24.1% 23.8% 23.2% 23.2% 22.9% 22.6% 22.3% 22.5% 22.7% 21.2% 23.2% 24.4% 23.1% 23.2% 23.3% 24.1% 23.2% 23.2% 23.9% 24.0% 25.0% 22.8% 26.9% 27.1% 25.6% 24.5% – – – -80.6% -891.6% 47.4% 48.6% 51.3% 51.1% 48.1%
0.5 0.4 0.5 0.5 0.5 0.3 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.3 0.3 0.4 0.5 0.5 0.5 0.3 0.3 0.4 0.7 0.3 0.3 0.2 0.2 – – – – – 0.8 0.8 0.7 0.7 0.7
Per Share
2.62 2.80 2.85 2.80 2.76 2.64 1.32 1.03 0.58 -0.37 0.31 0.21 0.67 1.83 3.58 4.06 4.62 4.91 4.07 4.24 3.85 2.43 1.78 0.64 0.07 1.21 1.55 3.70 5.91 7.93 – – – -1.00 -1.07 -1.01 -0.63 -0.23 0.12 0.37
9.75 10.47 10.76 10.89 11.02 11.53 12.32 13.02 13.90 14.78 15.43 16.06 16.48 16.89 17.29 17.52 19.42 21.06 22.39 23.73 24.98 25.10 24.35 24.00 22.07 20.33 18.06 17.12 17.73 18.92 – – – 1.47 1.78 1.93 2.18 2.80 3.21 3.50
18.95 20.00 20.90 21.55 22.11 22.55 22.71 23.34 23.96 23.99 23.98 24.17 24.70 25.39 27.98 30.13 31.69 35.73 36.33 37.32 38.61 39.14 39.77 39.59 39.06 39.48 39.12 41.45 43.27 45.67 -0.08 – – -0.99 -10.20 1.64 1.61 1.99 2.10 2.09
-4.69 -5.21 -7.93 -8.18 -11.22 -11.45 -11.94 -10.27 -7.41 -6.48 -6.39 -6.69 -5.96 -11.12 -17.22 -19.26 -24.05 -28.93 -32.81 -34.26 -27.41 -17.86 -3.74 3.10 4.52 8.69 3.21 -4.03 -8.57 -37.28 – – – -0.90 -0.83 -0.51 -0.05 0.23 0.44 0.52

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?